(R)-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability

Journal of Medicinal Chemistry

Volumn 37, Issue 12, 1994, Pages 1889-1893

  Abadji, Vasiliki ^a   Lin, Sonyuan ^a   Taha, Giban ^a   Griffin, Graeme ^b   Stevenson, Lesley A ^b   Pertwee, Roger G ^b   Makriyannis, Alexandros ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL 1' HYDROXY 2' PROPYLAMIDE; ARACHIDONYL 2' HYDROXY 1' PROPYLAMIDE; BENZYLSULFONYL FLUORIDE; BRAIN RECEPTOR; CANNABINOID; CANNABIS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; BINDING AFFINITY; BRAIN MEMBRANE; CHIRALITY; CONCENTRATION RESPONSE; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HYPOKINESIA; HYPOTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; NOTE; TAIL FLICK TEST; VAS DEFERENS;

AMINOPEPTIDASES; ANIMAL; ARACHIDONIC ACIDS; DRUG STABILITY; IN VITRO; MALE; MICE; MUSCLE CONTRACTION; PROSENCEPHALON; RECEPTORS, DRUG; STEREOISOMERISM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VAS DEFERENS;

EID: 0028246688     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00038a020     Document Type: Article

References (19)

1. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. Science 1992, 258, 1946-1949
2. Fride, E.; Mechoulam, R. Pharamcological Activity of the Cannabinoid Receptor Agonist, Anandamide, a Brain Constituent. Eur. J. Pharmacol. 1993, 231, 313-314
3. Vogel, Z.; Barg, J.; Levy, R.; Saya, D.; Heldman, E.; Mechoulam, R. Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase. J. Neurochem. 1993, 61, 352-355
4. Pertwee, R. G.; Stevenson, L. A.; Griffin, G. Cross-tolerance between Delta-9-tetrahydrocannabinol and the Cannabimimetic agents CP-55,940, WIN 55,212-2 and Anandamide. Br. J. Pharmacol. 1993, 110, 1483-1490
5. Munro, S.; Thomas, K. L.; Abu-Shaar, M. Molecular Characterization of a Peripheral Receptor for Cannabinoids. Nature 1993, 365, 61-65
6. Corey, E. J.; Cashman, J. R.; Kantner, S. S.; Wright, S. W. Rationally Designed, Potent Competitive Inhibitors of Leukotriene Biosynthesis. J. Am. Chem. Soc. 1984, 106, 1503-1504
7. Deutsch, D. G.; Chin, S. A. Enzymatic Synthesis and Degradation of Anandamide, a Cannabinoid Receptor Agonist. Biochem. Pharmacol. 1993, 46, 791-796
8. Childers, S. R. Personal Communication. 1993 International Cannabis Research Society, Ontario, Canada
9. Devane, W. A.; Dysarz, F. A., III; Johnson, R. M.; Melvin, L. S.; Hewlett, A. C. Determination and Characterization of a Cannabinoid Receptor in Rat Brain. Mol. Pharmacol. 1988, 34, 605-613
10. Charalambous, A.; Guo, Y.; Houston, D. B.; Howlett, A. C.; Compton, D. R.; Martin, B. R.; Makriyannis, A. 5′-azido-Δ8-THC: A Novel Photoaffinity Label for the Cannabinoid Receptor. J. Med. Chem. 1992, 35, 3076-3079
11. Pertwee, R. G.; Stevenson, L. A.; Elrick, D. B.; Mechoulam, R.; Corbett, A. D. Inhibitory Effects of Certain Enantiomeric Cannabinoids in the Mouse Vas Deferens and the Myenteric Plexus Preparation of Guinea-pig Small Intestine. Br. J. Pharmacol. 1992, 105, 980-984
12. Pertwee, R. G. The Evidence for the Existence of Cannabinoid Receptors. Gen. Pharmacol. 1993, 24, 811-824
13. Martin, B. R.; Compton, D. R.; Thomas, B. F.; Prescott, W. R.; Little, P. J.; Razdan, R. K.; Johnson, M. R.; Melvin, L. S.; Mechoulam, R.; Ward, S. J. Beharvioral, biochemical and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 1991, 40, 471-478
14. Pertwee, R. G.; Stevenson, L. A. Effect of pretreatment with delta-9-tetrahydrocannabinol on the ability of certain cannabimimetic agents to induce hypothermia in mice. In: Temperature Regulation. Recent Physiological and Pharmacological Advances; Milton, A. S., Ed.; Birkhäuser: Basel, 1994; pp 177-182
15. Felder, C. C.; Briley, E. M.; Axelrod, J.; Simpson, J. T.; Mackie, K.; Devane, W. A.:Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 7656-7660
16. Cheng, Y. C.; Prusoff, W. H. Relationship between the inhibition constant (K¡) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3102
17. Pertwee, R. G. The ring test: A quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice. Br. J. Pharmacol. 1972, 46, 753-763
18. D'Amour, F. E.; Smith, D. L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 1941, 72, 74-79
19. Compton, D. R.; Johnson, M. R.; Melvin, L. S.; Martin, B. R. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 1992, 260, 201-209